Med school with strong tech touch
|
02 September 10
The Strait Times by Salma Khalik, Health Correspondent
SINGAPORE'S third medical school will produce a different breed of doctors from the two other schools here. Its graduates will be trained to tap cutting-edge technology such as robotics to treat patients, said Nanyang Technological University (NTU) president Su Guaning. The school will not only train the best clinicians, but will also be at the forefront of innovating medical devices and ...
|
|
NTU-Imperial medical school to admit 50 students in 2013
|
02 September 10
The Business Times
SINGAPORE'S third medical school will take in its first 50 students in 2013, Education Minister Ng Eng Hen said on Tuesday, sharing details on the partnership between Nanyang Technological University (NTU) and Imperial College London. It is one of two new developments in the tertiary education sector slated to better meet industry demand, the other being the Ministry of Education's (MOE) plans to ...
|
|
2 other diseases under control
|
01 September 10
The Strait Times
- CHIKUNGUNYA Singapore's National Environment Agency (NEA) yesterday declared that the painful mosquito-borne disease chikungunya was not endemic here. But there had been cause for concern earlier because the viral illness, which first cropped up here through three imported cases in 2006, hit 718 people in 2008, partly as a result of a local outbreak. Mosquito-control measures reduced the ...
|
|
Dengue outbreak cycle broken: NEA
|
01 September 10
The Strait Times by Grace Chua
THE six- to seven-year cycle of dengue outbreaks has been broken, and chikungunya and malaria have also been brought under control, the National Environment Agency (NEA) announced yesterday. With dengue, the number of cases typically rises over a period of six years or so, and then climaxes in a major outbreak, explained Mr Tai Ji Choong, who heads operations at NEA's environmental health ...
|
|
Far East launches Novena Specialist Center
|
31 August 10
The Business Times by Uma Shankari
FAR East Organization yesterday released for lease 31 out of the 69 medical suites at its upcoming Novena Specialist Center. Ranging in size from 549 to 1,442 square feet, they will be rented out for $8-9 per sq ft (psf). Novena Specialist Center is part of a $350 million hotel and commercial complex the developer is building. Besides the 69 suites, the project will also house a 428-room Oasia ...
|
|
Trial of S'pore-designed tiny heart monitor a success
|
26 August 10
The Strait Times
HEART patients wearing portable monitoring devices usually have to put up with unsightly wires held in place with sticky tape, and lug around a bulky box weighing 500g. But such monitors could soon be history when a designed-in-Singapore device, half the size of a credit card and weighing all of 26g, is commercialised. The Spyder, as it has been called, was put through its paces recently by 20 ...
|
|
Better treatment for some cancers
|
26 August 10
The Strait Times by Lester Kok
A NEW method of treating certain cancers - which is more precise, reduces treatment time and minimises side effects - has been introduced by the National University Health System (NUHS). Used on patients suffering from prostate, breast and cervical cancer, the radiotherapy known as high-dose rate (HDR) brachytherapy involves inserting thin hollow tubes or catheters into the body to deliver ...
|
|
Biotech sector gets top marks but local players are surprised
|
25 August 10
The Business Times by Chen Huifen
(SINGAPORE) Singapore has trumped the UK and other well known biotech hotspots to become the No 2 in the world for its capacity to nurture biotechnology innovation, according to a study conducted by a US magazine. But several local biotech players feel that the report flatters Singapore and that it still has some way to go before it deserves this prime perch. In a report titled 'A Global ...
|
|
Fusionopolis' Solaris 60% leased
|
17 August 10
The Business Times by Emilyn Yap
SOLARIS, an extension of the Fusionopolis research cluster at Buona Vista, has been 60 per cent leased ahead of its completion by the end of the year. The developer Soilbuild Group is in 'advanced negotiations' with other potential tenants. Soilbuild's executive director Low Soon Sim gave BT these updates following the release of the company's second quarter results last week. Organisations ...
|
|
Griffin jumps onto pharma wagon
|
10 August 10
The Business Times
HAVING forged a strong position in spare parts logistics for the marine and offshore sectors, home-grown Griffin Kinetic now wants to penetrate the pharmaceutical logistics industry as well. 'We're not moving away from what we've been doing for the past 21 years,' says managing director Gerry Tan. 'It's just a lateral expansion of what we are doing. 'If you have followed A*Star and even Spring ...
|
|
S'pore team on trail of aspirin answer to colorectal cancer
|
04 August 10
The Business Times by Chen Huifen
(SINGAPORE) Could over- the-counter aspirin be an answer for patients suffering from colorectal cancer? That's the question the National Cancer Centre Singapore (NCCS) hopes to answer in the large-scale clinical trial it is leading on the efficacy of the drug that is usually associated with pain relief and colds. The NCCS team, led by head of medical oncology Toh Han Chong and medical ...
|
|
Trial to test aspirin in colon cancer treatment
|
04 August 10
The Strait Times by Judith Tan
A SIMPLE aspirin pill might be the answer to the growing colon cancer headache. The effect of aspirin on the world's third most common cancer has been of much debate in the past year. Now, cancer doctors here are to start a multi-centre clinical trial across Asia to see how effective the off-the-counter painkiller is in reducing the risk of colon cancer recurring after surgery or chemotherapy. It ...
|
|
New hope for women with breast or ovarian cancer
|
04 August 10
The Strait Times by Salma Khalik, Health Correspondent
CANCER specialists are eagerly awaiting the large-scale trial of a powerful new drug that spells hope for some women stricken with breast or ovarian cancer. It is expected to start soon, given the drug's good showing in early trials. The new class of drugs, called parp inhibitors, targets cancers in women who have a certain mutation in their genes, for whom conventional treatment has failed. The ...
|
|
New nanotech unit learns from nature
|
04 August 10
The Strait Times by Victoria Vaughan
LOTUS leaves grow from muddy soil yet remain clean without the use of soap, a gecko can stick to the ceiling without any glue, and butterfly wings shimmer with colour with no chemical dyes.A new research collaboration hopes to translate these natural 'skills' into everyday products.The Industrial Consortium on Nanoimprint (Icon), launched yesterday, brings together scientists from the Agency for ...
|
|
Bioengineering, nanotech conference begins
|
03 August 10
The Business Times
MORE than 300 international delegates have gathered at Biopolis to discuss the latest research on bioengineering and nanotechnology. They are in town for the fifth International Conference on Bioengineering and Nanotechnology (ICBN), a three-day event that kicked off yesterday. The conference has been organised by Singapore's Institute of Bioengineering and Nanotechnology (IBN) and is chaired by ...
|
|
|